Objective:

To investigate the implications of color vision deficiency (CVD) on cancer outcomes, specifically bladder and colorectal cancer, and how it affects patient awareness of symptoms.

Key Findings:

• Patients with bladder cancer and CVD had significantly worse overall survival compared to matched controls, indicating a critical need for awareness.
• A long-term analysis showed a 52% higher 20-year mortality rate in bladder cancer patients with CVD.
• No survival difference was observed for colorectal cancer patients with CVD compared to controls.

Interpretation:

The findings suggest that CVD may impact the clinical outcomes of bladder cancer due to the inability to detect visible blood, highlighting the need for heightened vigilance in these patients.

Limitations:

• The study is retrospective and may not account for all confounding factors, including potential biases.
• Findings are hypothesis-generating and require further investigation.

Conclusion:

Patients with CVD should not dismiss the absence of visible blood as a sign of low suspicion for bladder cancer; clinicians should maintain a high index of suspicion.

Sources:

• Nature Health